Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of Yokukansankachimpihange (TJ-83) in irritable bowel syndrome
jRCTs021190011Active, not recruiting
- Sponsor
- Tsumura & Co.
- Start
- Jul 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of yokukansankachimpihange in irritable bowel syndrome (IBS), anxiety disorder and Insomnia (2 arms), sponsored by Tsumura & Co. Primary endpoint: Change in STAI State Anxiety Inventory score at 12 weeks. Started Jul 2020; status: active, not recruiting.
02
Drugs
yokukansankachimpihange
03
Conditions
irritable bowel syndrome (IBS)anxiety disorderInsomnia
Beyond the preview
Go deeper on jRCTs021190011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021190011.